Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Alitair Pharmaceuticals logo — Helping the World Breathe Easier

Alitair Pharmaceuticals

Helping the World Breathe Easier

Founded 2010 United States Hingham, United States 2 employees Biotechnology, Life Sciences +1

General Information

Company Name Alitair Pharmaceuticals
Founded Year 2010
Location United States Hingham, United States +1
Founders / Decision Makers
Team member
Employees 2
Industries Biotechnology, Life Sciences, Pharmaceutical
Social

Get notified when Alitair Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Alitair Pharmaceuticals

Alitair Pharmaceuticals is a specialty pharmaceutical company dedicated to addressing unmet medical needs in the respiratory space. Through their proprietary ion-exchange resin formulations and prescription cough medicines, as well as a pipeline of orphan drugs, they aim to provide innovative solutions for patients. The company has a robust pipeline, including a patented Overdose Reduction formulation (ODR) designed to mitigate the risk of prescription drug overdose, and plans for internal product development, out-licensing opportunities, and strategic partnerships to further their corporate goals. Established in 2010, Alitair is focused on expanding its presence in the global pharmaceutical market. For more detailed information on the company, its pipeline, and business development strategies, please visit their website.

Taxonomy: Respiratory Pharmaceuticals, Orphan Drugs, Prescription Cough Medicines, Ion-Exchange Resin Formulations, Drug Formulation Technology, Patent Protection, Pipeline Development, Business Development Strategy, Out-Licensing Opportunities, Strategic Alliances, Global Pharmaceutical Expansion, Bronchiectasis Treatment, Opioid Abuse Deterrence, Non-Narcotic Prescription Drugs, Overdose Reduction Technology

No funding data available for Alitair Pharmaceuticals yet.

Get notified when Alitair Pharmaceuticals raises funding

FAQ About Alitair Pharmaceuticals

Helping the World Breathe Easier
Alitair Pharmaceuticals was founded in 2010.
Alitair Pharmaceuticals is headquartered in Hingham, United States.
Alitair Pharmaceuticals operates in the following industries: Biotechnology, Life Sciences, Pharmaceutical.
Alitair Pharmaceuticals has approximately 2 employees.

We're actively collecting intelligence on Alitair Pharmaceuticals.

Track Alitair Pharmaceuticals to get notified

Don't just browse. Track.

Signal Tracker monitors Alitair Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy